Millions of botulinum toxin injections have been performed worldwide. However, not all of them were done with contraindications taken into account, and not all patients were satisfied with the results.
AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.
Today, cosmetologists fight against oily skin, acne, wrinkles, dark circles under the eyes, and other human imperfections.
About the project
EstPortal.com (Aesthetic Portal) – is a professional resource dedicated to beauty. The project will be of interest to both beauty industry specialists and its connoisseurs. The aim of the project: to provide maximum time saving on search of necessary information for beauty industry specialists and site visitors.